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Objectives. In this study we tested the hypothesis that immuni-
zation with homologous oxidized low density lipoprotein (oxLDL)
would inhibit the neointimal response to balloon injury in hyper-
cholesterolemic rabbits.
Background. Immunization with homologous oxLDL has been
shown to markedly reduce aortic atherosclerosis in LDL receptor-
deficient as well as cholesterol-fed rabbits; however, the effect of
this strategy on the balloon injury-induced neointimal lesion is
unknown.
Methods. New Zealand White rabbits were immunized with
280 mg of homologous native LDL (n 5 5), copper-oxidized LDL
(n 5 5) or phosphate buffer as control (n 5 5) and fed a 1%
cholesterol diet. Rabbits were reimmunized after 3 weeks, and
balloon injury of the right ileofemoral artery was performed 1
week later. Four weeks after balloon injury, rabbits were killed,
and the neointimal lesion area was measured by computerized
morphometry after perfusion fixation of the arteries. Circulating
antibodies against oxLDL were measured by enzyme-linked im-
munosorbent assay.
Results. In comparison with the control animals, those immu-
nized with oxLDL had a 58% reduction in the neointimal area
(0.53 6 0.13 vs. 1.27 6 0.26 mm2; p 5 0.01). The group immunized
with native LDL had a 19% reduction in the neointimal area
compared with the control group (p 5 NS). Circulating choles-
terol levels and antibody titers against oxLDL were comparable in
the three groups. There was a trend toward reduced immunore-
activity for T cells and oxLDL in the neointima of oxLDL-
immunized animals.
Conclusions. Hypercholesterolemic rabbits immunized with
homologous oxLDL have a markedly reduced neointimal area
after balloon injury despite severe hypercholesterolemia. Together
with previous work, these data suggest that an immunization
strategy (vaccination) against atherosclerosis and restenosis war-
rants further investigation.
(J Am Coll Cardiol 1997;30:1886–91)
©1997 by the American College of Cardiology
The presence of activated T cells and human leukocyte anti-
gen, DR type–expressing macrophages, smooth muscle cells
(SMC) and endothelial cells in atherosclerotic plaques have
suggested the involvement of the immune system in athero-
sclerosis (1–3). An enhanced plaque formation has generally
been observed in animals immunized with foreign antigen (4)
and after allograft transplantation (5), suggesting that activa-
tion of the immune system promotes intimal inflammation and
fibrosis, which characterize the development of atherosclero-
sis. However, this concept has recently been challenged by
studies showing that suppression of T cell function by cyclo-
sporin A enhances the development of atherosclerosis in
hypercholesterolemic mice (6) and rabbits (7) and that class
I–deficient mice have an increased susceptibility to atheroscle-
rosis (8). The vascular wall response to mechanical injury may
also be modulated by the immune system. Thus, T cell–
deficient rats develop larger neointimal lesions in response to
balloon catheter injury than do rats with normal T cell function
(9). Similar observations have also been made in rabbits after
T cell suppression by cyclosporin A (10), adding further
support to the notion that cell-mediated immune reactions
may modulate arterial response to injury.
Several lines of evidence implicate low density lipoprotein
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(LDL) oxidation in atherogenesis in experimental animals and
in humans (11,12). Oxidized LDL (oxLDL) modulates activa-
tion of plaque T cells (13) through a macrophage-dependent
process (13,14). Oxidized LDL has been proposed as one
possible target for the immune response in atherosclerosis.
Antibodies against epitopes of oxLDL are present both in the
circulation and in atherosclerotic plaques (12,15,16). However,
until recently, the role of the immune response against oxLDL
in the pathophysiology of atherosclerosis has remained ob-
scure. Recently, the role of the immune response to oxLDL in
the formation of early atherosclerotic lesions in the aortas of
rabbits has been evaluated. Reduced plaque formation after
immunization with homologous oxLDL was observed both in
genetically hypercholesterolemic rabbits (17) and in rabbits
with diet-induced hypercholesterolemia (18). However, the
effect of the immune response to oxLDL on neointimal lesion
formation after balloon injury has not been previously studied.
Therefore, the goal of this study was to test the hypothesis that
immunization with oxLDL would reduce neointimal formation
after balloon injury in the hypercholesterolemic rabbit.
Methods
Preparation of native and oxLDL. New Zealand White
rabbits with diet-induced hypercholesterolemia (total serum
cholesterol levels of 800 to 1,200 mg/dl) were killed by an
intravenous overdose of fluanizone and penthanyl. Blood was
drawn into precooled vacutainer tubes containing Na2EDTA
(1.4 mg/ml) from a catheter placed in the carotid artery.
Plasma was then recovered by centrifugation at 1400 3 g for
20 min at 1°C. The isolated plasma was adjusted to a density of
1.10 kg/liter by addition of NaCl. A density gradient consisting
of 3 ml of 1.065-, 1.020- and 1,006-kg/liter NaCl solutions,
respectively, was then formed in cellulose nitrate tubes (Ultra-
clear tubes, Beckman) and centrifuged (Beckman L8-55 Ultra-
centrifuge, 40,000 rpm) in a Beckman SW 40 swinging bucket
rotor at 20°C overnight (19). The very low density lipoprotein
fraction was aspirated from the top 3 ml and intermediate
density lipoprotein and LDL were harvested from the next 3 ml
of the tube. The EDTA was subsequently removed by dialysis
against EDTA-free phosphate-buffered saline (PBS). The pro-
tein content of the LDL preparation was determined by the
method described by Lowry et al. (20). The LDL was oxidized
by incubation in 5.0 mmol/liter CuSO4/PBS for 18 h at 37°C,
and the oxidative modification was determined by agarose gel
electrophoresis.
Animals and immunizations. Young male New Zealand
White rabbits with an average weight of 3.5 kg were housed
individually under conditions of 12-h light/dark periods. The
animals were fed standard rabbit pellets supplemented with
1% cholesterol and 3% peanut oil for the entire duration of
the study. On the first day of initiation of a high cholesterol
diet, rabbits were immunized with native LDL (n 5 5), oxLDL
(n 5 5) or PBS as control (n 5 5). Each animal was given
280 mg of respective lipoprotein emulsified in 700 mg of
AdjuPrime (Pierce) or AdjuPrime/PBS alone by subcutaneous
injections at multiple sites. Reimmunization using an identical
protocol was performed 3 weeks later. The decision to use
AdjuPrime rather than Freunds complete adjuvans was based
on earlier reports that the immune reaction against heat shock
protein present in Freunds complete adjuvans produces severe
atherosclerosis in hypercholesterolemic rabbits (21).
One week after the second immunization all animals were
subjected to balloon injury of the right femoral artery. The
animals were anesthetized using ketamine (35 mg/kg body
weight) and xylazine (5 mg/kg). Using standard sterile tech-
nique, a right carotid artery cutdown was performed and a
2.5-mm angioplasty catheter was introduced with a guide wire
(high torque-floppy 0.014). Under fluoroscopic guidance, the
catheter was advanced through the aorta to the right femoral
artery. The balloon was then inflated to a constant pressure of
8 atm for 1 min. This step was repeated with a 1-min interval,
at the end of which the inflated balloon was retracted to the
bifurcation of the common iliac arteries and deflated. The
catheter and wire were removed, the right carotid artery
ligated and the overlying skin sutured. All animals were
returned to their housing fully awake, and routine postopera-
tive care and follow-up were instituted. Four weeks after the
injury, the animals were anesthetized, as described, and exsan-
guinated while being perfused with 0.9% normal saline fol-
lowed by 4% paraformaldehyde in 0.1 mol/liter PBS (pH 7.2)
under constant pressure of 100 ml of water for 20 min. The
ileofemoral arteries were removed and placed in 4% formal-
dehyde with 0.2 mmol/liter EDTA and 20 mmol/liter butylated
hydroxytoluene (BHT) for 3 h and then transferred to a
solution containing 15% sucrose with 0.2 mmol/liter EDTA
and 20 mM BHT and kept overnight at 4°C. The protocol for
animal use was approved by Cedars-Sinai Institutional Animal
Care and Use Committee.
Serum cholesterol levels were determined by enzymatic
technique (Sigma) at the start of the study, at the time of injury
and at the time of death.
ELISA for antibodies against oxLDL. Ninety-six–well
ELISA microtiter plates (Costar) were coated with buffer
(0.2 mol/liter sodium bicarbonate buffer, pH 9.4) containing
10 mg/ml of native or oxidized human LDL for 2 h at 20°C.
Human LDL was isolated from healthy control subjects by the
same technique as described earlier for isolation of rabbit
LDL. The coated wells were rinsed in washing buffer (PBS/
0.1% bovine serum albumin [BSA]/0.05% Tween 20) and
Abbreviations and Acronyms
BHT 5 butylated hydroxytoluene
BSA 5 bovine serum albumin
ELISA 5 enzyme-linked immunosorbent assay
IgG 5 immunoglobulin G
LDL 5 low density lipoprotein
oxLDL 5 oxidized low density lipoprotein
PBS 5 phosphate-buffered saline
SMC 5 smooth muscle cells
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incubated with blocking buffer (PBS/1% BSA) for 1 h at 20°C.
The test sera were serially diluted in blocking buffer and added
to the wells for overnight incubation at 20°C. The wells were
then washed extensively with washing buffer and incubated
with peroxidase-labeled goat antihuman immunoglobulin G
(IgG) antibodies (diluted 1/4,000 in blocking buffer) for 2 h at
20°C. After repeated rinsing in washing buffer, the plates
were developed by incubation with 2,29-azino-bis-(3-
ethylbenzothiazoline sulfonate) (ABTS) for 30 min at 20°C
and read in an ELISA reader at 405 mm. Oxidized LDL
specific antibody titers were expressed as units (oxLDL absor-
bance 3 100).
Immunohistochemical and morphometric analysis. Three
1-mm long segments of arterial tissue were taken at 5-mm
intervals starting 10 mm below the bifurcation. All tissue
specimens were mounted in optimal cutting temperature me-
dium for cryosectioning. Sections 10 mm thick were mounted
on polysialynated glass slides, rinsed in PBS and incubated with
blocking serum for 1 h. They were then incubated with
antibodies against rabbit macrophages (RAM 11, Dako), rab-
bit lymphocytes (L 11/129, courtesy of Prof. Goran Hansson,
Stockholm, Sweden), oxLDL (courtesy of Prof. Joseph Witz-
tum, San Diego, California), rabbit class II antigen (2C4) or
SMC-specific alpha-actin (Dako) dissolved in PBS/0.1% Triton
X-100 for 18 h in a humidifying chamber. Control specimens
included an irrelevant antibody as well as omission of the
primary antibody. The sections were subsequently rinsed in
PBS, incubated with biotinylated antimouse IgG for 60 min,
rinsed in PBS and incubated with alkaline phosphatase-labeled
biotin streptavidin complexes for 2 h. The cells were finally
incubated with alkaline phosphatase substrate solution for
30 min in darkness and counterstained with hematoxylin.
Sections for morphometric analysis were stained with hema-
toxylin. Neointimal area was determined using the Optimas
image analysis as described (22). The interobserver and in-
traobserver variabilities of the measurements were ,5%. A
mean value of intimal lesion area was calculated based on
measurements of three sections taken at 5-mm intervals start-
ing 10 mm below the bifurcation. Semiquantitative analysis of
the immunohistochemistry staining was performed using a
modified version of the technique described by Galis et al. (23).
Consistent positive staining covering .50% of the intima was
recorded as 3; consistent positive staining covering ,50% of
the intima as 2; variable or weak staining as 1; and no staining
as 0. Results are presented as the average score.
Statistical analysis. Results are presented as mean value 6
SD if not otherwise indicated. The nonparametric Wilcoxon
signed-rank test was used for intergroup analysis. A p value
,0.05 was considered significant.
Results
The mean serum cholesterol level before dieting was
#40 mg/dl. After 4 weeks of a high cholesterol diet, cholesterol
levels had increased to ;600 to 700 mg/dl. At the time of
death, cholesterol levels were .1,000 mg/dl. There were no
significant differences in serum cholesterol levels between the
three treatment groups (Table 1). No antibodies against
oxLDL were detected in sera taken before immunization and
initiation of the cholesterol-rich diet. At the time of death,
antibodies against oxLDL were present in the sera of all three
groups of animals (Fig. 1).
Neointimal lesion formation in response to balloon injury.
All animals developed concentric intimal lesions in response to
the injury. The mean neointimal area of animals immunized
with adjuvant/PBS alone was 1.27 6 0.26 mm2. Immunization
with oxLDL reduced the intimal lesion area by 58.2% (p 5
0.01), as compared with adjuvant alone, whereas immunization
with LDL reduced the intimal lesion area by 19% (p 5 NS)
(Fig. 2).
Immunohistochemical analysis. Immunohistochemical
analysis demonstrated abundant SMC immunoreactivity in all
neointimal lesions, as well as in the underlying media. Macro-
phage immunostaining was also seen in the entire neointima
but was particularly prominent in the deeper regions close to
the internal elastic lamina (Fig. 3, A and D). Areas with visible
lipid accumulation and necrosis were always associated with
intense macrophage staining. The immunohistochemical anal-
ysis also revealed abundant T cell infiltration in the deeper
regions of the lesions, whereas few T cells appeared to be
Table 1. Total Serum Cholesterol Levels (mg/dl)
Adjuvant
Group
(n 5 5)
LDL
Group
(n 5 5)
oxLDL
Group
(n 5 5)
Pretreatment 28 6 8 30 6 10 37 6 15
4 weeks 659 6 423 727 6 301 591 6 324
8 weeks 1,181 6 322 1,321 6 159 1,022 6 481
Data presented are mean value 6 SD. LDL 5 low density lipoprotein;
oxLDL 5 oxidized low density lipoprotein.
Figure 1. Antibodies to oxLDL. These antibodies were determined by
ELISA before immunization (solid circles) and at the end of the study
in animals immunized with native (open squares) or oxidized (open
circles) LDL and in control rabbits (open triangles). Antibody titers
were analyzed in two animals from each group.
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present in the superficial region (Fig. 3, B and E). Epitopes
specific for oxLDL were also primarily present in the deeper
regions of the lesions (Fig. 3, C and F). Most of the oxLDL
immunoreactivity was associated with foam cells. Accumula-
tion of lipids, necrosis and oxLDL, T cell and macrophage
immunoreactivity were also seen in some parts of the media.
Generally, larger lesions had more lipid accumulation, necrosis
and inflammatory cell infiltrates.
To compare the immunohistochemical staining between the
three different treatment groups, we performed a semiquanti-
tative analysis of staining intensity. The overall intensity of the
macrophage stain appeared to be weaker in animals immu-
nized with oxLDL, but there was no difference in the area
stained. There were fewer T cells in lesions from animals
immunized with LDL and to a lesser extent in animals
immunized with oxLDL (Table 2).
Discussion
This study demonstrates, for the first time, that immuniza-
tion of cholesterol-fed rabbits with homologous oxLDL mark-
edly reduces neointimal formation in the balloon-injured iliac
artery despite persistent severe hypercholesterolemia. Further-
more, these favorable effects were observed without any dif-
ference in the magnitude of humoral immune response, as
measured by circulating antibodies against oxLDL, between
control animals and immunized animals, suggesting that cell-
Figure 2. Effect of immunization on neointimal development after
balloon injury. Balloon injury to the right ileofemoral artery was
performed 1 week after the reimmunization, and the animals were
killed 4 weeks later. The mean neointimal lesion area for each animal
was determined by image analysis of three sections taken at 5-mm
intervals starting 10 mm below the bifurcation. Data are presented as
mean value 6 SD for each group. *p 5 0.01 versus the PBS control
group.
Figure 3. Immunohistochemical analysis of neointimal le-
sions. RAM-11 macrophage staining in (A) a femoral artery
from a rabbit given adjuvant/PBS and (D) a rabbit immunized
with oxLDL. L11/135 T lymphocyte staining in (B) a femoral
artery from a rabbit given adjuvant/PBS and (E) an artery
from a rabbit immunized with oxLDL. (C) Staining for oxLDL
(NA 59) in an artery from a rabbit given adjuvant/PBS and (F)
the same staining in an artery from a rabbit immunized with
oxLDL. Arrows indicate the internal elastic lamina. 3100,
reduced by 30%.
Table 2. Semiquantitative Analysis of
Immunohistochemical Staining
Adjuvant
Group
(n 5 5)
LDL
Group
(n 5 5)
oxLDL
Group
(n 5 5)
SMC (HHF35) 3.0 6 0.0 3.0 6 0.0 3.0 6 0.0
Macrophage (RAM-11) 3.0 6 0.0 3.0 6 0.0 3.0 6 0.0
T cells (L11/135) 2.4 6 0.5 1.4 6 0.5* 1.8 6 0.5
Class II antigen (2C4) 1.5 6 0.6 1.4 6 0.5 1.0 6 1.4
oxLDL (NA 59) 2.8 6 0.5 3.0 6 0.0 1.8 6 1.5
*p , 0.05 compared with the adjuvant group. Results are presented as mean
value 6 SD of the average score. Consistent positive staining covering .50% of
the intima was scored as 3; covering ,50% of the intima as 2; variable or weak
staining as 1; and no staining as 0. SMC 5 smooth muscle cells; other
abbreviations as in Table 1.
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mediated rather than humoral immunity may be involved.
Taken together with previously reported results in hypercho-
lesterolemic rabbits, these data further suggest a beneficial
effect of immune response in atherosclerosis (17,18).
Arterial accumulation of LDL is a key factor in the
development of atherosclerotic plaques (24). The LDL parti-
cles, trapped in the extracellular matrix of the vascular wall, are
known to undergo substantial structural and chemical modifi-
cations in response to oxidative stress, enzymes and/or other
unknown factors (25–27). These modifications include oxida-
tion of fatty acids into lipid hydroperoxides, which are then
decomposed into a variety of products including reactive
aldehydes. Interactions between these aldehydes and lysine
residues on apolipoprotein B 100 results in formation of
epitopes that are recognized by the immune system (28,29).
Atherosclerotic plaques contain both antibodies against
oxLDL (16) and T cells that specifically recognize epitopes in
oxLDL (13), suggesting involvement of humoral as well as
cell-mediated immune responses. An immune response against
autologous modified lipoproteins could represent an underly-
ing mechanism for the chronic intimal inflammatory process
seen in atherosclerosis. However, we and another group of
investigators have recently demonstrated decreased formation
of fatty streaks and early atherosclerotic lesions in hypercho-
lesterolemic rabbits immunized with homologous oxLDL
(17,18). The present observation that immunization with ho-
mologous oxLDL inhibits neointimal formation after balloon
injury of the ileofemoral artery in hypercholesterolemic rabbits
adds further support to the notion that immune reactions
against oxLDL serves to limit the atherosclerotic process.
Possible mechanisms involved in antiatherogenic effect of
immune reactions against oxLDL. The mechanisms responsi-
ble for the protective effect of immunization against homolo-
gous oxLDL remain to be clarified. Although the level of
antibodies against oxLDL increased significantly in animals
immunized with oxLDL, a similar increase in antibodies was
observed in response to diet-induced hypercholesterolemia
alone, demonstrating that mechanisms other than humoral
immunity may be involved. Similarly, it has been shown that
diet-induced hypercholesterolemia in LDL-deficient mice re-
sults in induction of a humoral immune response against
oxLDL (30). Thus, it appears that hypercholesterolemia, in
itself, is associated with the formation of oxidized epitopes on
LDL and activation of a humoral immune response toward
these epitopes. Previous immunization with oxLDL may have
stimulated the onset of this response, but did not appear to
influence its final magnitude. However, we cannot definitively
rule out the role of humoral immunity, because epitopes other
than the ones identified in this study could be involved.
Nevertheless, these findings are in keeping with the observa-
tions of Roselaar et al. (7), who found that suppression of T
cell function by cyclosporin A in rabbits with diet-induced
hypercholesterolemia resulted in enhanced development of
atherosclerosis without affecting serum levels of antibodies
against malondialdehyde-modified LDL. Of note is the finding
in this study that there was neither decreased T cell infiltration
nor any detectable change in T lymphocyte subtype expression
in the lesion of the treated animals. Further evidence for a role
of cell-mediated immunity in atherosclerosis has come from
studies on class I major histocompatibility complex–deficient
C57BL/6 mice (8). These animals lack cytolytic T cells, have an
impaired natural killer cell activity and have an increased
tendency to develop aortic lesions in response to a high
cholesterol diet. Semiquantitative analysis of neointimal le-
sions in animals immunized with oxLDL showed a trend
toward reduced immunoreactivity for T cells (Table 2). This is
unlikely to explain the difference in neointimal area, because T
cell immunoreactivity was also reduced in animals immunized
with native LDL who only had a 19% reduction in neointimal
area compared with a 58% reduction observed with immuni-
zation with oxLDL. Although in this study we did not evaluate
T cell function, other studies suggest altered T cell function
could be involved in modulating the severity of diet-induced
atherosclerosis (10). Activation of a cell-mediated immune
response against oxLDL may facilitate the removal of oxLDL
from the intima, thereby limiting the inflammatory reaction.
The trend toward a reduced immunoreactivity for oxLDL in
the neointima of animals immunized with oxLDL (Table 2) is
consistent with this hypothesis.
Immune reactions may lead to a more efficient removal of
proinflammatory and mitogenic lipid oxidation products. An-
other possibility is that an enhanced clearance of oxLDL
results in a decreased proliferation of SMC. Oxidized LDL has
been shown to activate the monocyte release of tumor necrosis
factor-alpha, a potent growth factor for SMC (31). Lysophos-
phatidylcholine, which is formed in large quantities during
oxidative modification of LDL, also has a direct stimulatory
effect on the rate of SMC DNA synthesis (32). Several studies
demonstrating that antioxidants inhibit neointimal formation
after arterial balloon injury in hypercholesterolemic animals
(33,34) have supported the idea that oxidation products en-
hance the proliferative response after mechanical injury. The
proliferative response may also be modulated by factors re-
leased by activated T cells. Inhibition of T cell function by
treatment with cyclosporin A results in increased neointimal
formation in response to mechanical injury in normocholester-
olemic rabbits (10). Moreover, removal of T cells with mono-
clonal antibodies has been shown to enhance neointimal
formation after balloon injury of rat aortas (9). A similar effect
was also obtained by treatment with interferon-gamma (35),
which in cell culture has been identified as a potent inhibitor of
SMC proliferation (36). Stimulation of interferon-gamma re-
lease by T cells may thus be another possible explanation for
the decreased neointimal formation observed in animals im-
munized with oxLDL. Although one may speculate that acti-
vation of a cell-mediated immune reaction against oxLDL,
leading to enhanced clearance of proinflammatory and mito-
genic lipid oxidation products, are responsible for the effects
observed in the present study, further studies are clearly
needed to identify the precise mechanism(s) involved.
Conclusions. The present findings add further support to
the hypothesis that immune reactions against modified li-
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poproteins inhibit the formation of intimal plaques. Whether
this mechanism has implications for the development of ath-
erosclerosis and restenosis after balloon angioplasty in humans
remains to be determined. Nonetheless, this and previously
reported beneficial effects of immunization with homologous
oxLDL suggest that further investigation into the development
and validation of an immunization-based strategy (vaccination)
against atherosclerosis is warranted.
Study limitations. The major limitation of this study is the
fact that it does not provide a mechanistic insight into how
immunization with oxLDL reduces neointimal thickening after
balloon injury. Our laboratory is currently engaged in studies
designed to answer this important question.
We thank Professor Goran Hansson from the Karolinska Institutet for helpful
discussions related to this study.
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